Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EDUCATE-AMI: Diltiazem, Verapamil, and Nitroglycerin for No-reflow in AMI
NCT00712894Phase 4Completed
- Sponsor
- Fudan University
- Start
- Dec 2006
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of diltiazem in acute myocardial infarction (AMI) (3 arms), sponsored by Fudan University. Primary endpoints: TIMI flow grade and TIMI frame count. Started Dec 2006; status: completed.
02
Drugs
diltiazem
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT00712894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00712894.